Overview
Paul Chamberlin holds the position of Venture Partner at F-Prime as of September 2025[1][2]. Chamberlin's career has centered on clinical development and medical leadership across pharmaceutical companies. Chamberlin served as Head of Clinical Development at Imbria Pharmaceuticals from November 2018 to July 2024[4], followed by a role as Vice President of Clinical Development at Anthos Therapeutics from July 2024 to September 2025[3]. Earlier positions included Chief Medical Officer at Ventrix, Inc[6], Senior Medical Director at Ironwood Pharmaceuticals[5], and Vice President of Medical Development at Sequel Pharmaceuticals[8]. Chamberlin holds a Bachelor of Arts in Biology from the University of Pennsylvania[10], a Doctor of Medicine from Boston University School of Medicine[11], and completed clinical training as a resident physician at Mount Auburn Hospital through Harvard Medical School[12].
Career history
- Venture PartnerSep 2025 to presentF-Prime
- Vice President, Clinical DevelopmentJul 2024 to Sep 2025Anthos Therapeutics
- Head of Clinical DevelopmentNov 2018 to Jul 2024Imbria Pharmaceuticals
- Senior Medical DirectorNov 2015 to Nov 2018Ironwood Pharmaceuticals
- Chief Medical OfficerOct 2011 to Nov 2015Ventrix, Inc
- ConsultantFeb 2012 to Oct 2015Prism Biolabs
- Vice President, Medical DevelopmentSep 2007 to Jul 2011Sequel Pharmaceuticals
- Vice President, Medical Development2007 to 2007NovaCardia
Education
Bachelor of Arts - BA, BiologyUniversity of Pennsylvania
Doctor of Medicine - MDBoston University School of Medicine
Clinical Fellow/Resident Physician/Mount Auburn HospitalHarvard Medical School
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.